LRRC4B, or Leucine-Rich Repeat Containing 4B, is a protein encoded by a gene of the same name and is part of the larger family of leucine-rich repeat (LRR) proteins. These proteins are known for their involvement in a multitude of cellular functions, including signal transduction, cell adhesion, and the immune response, primarily through protein-protein interactions facilitated by their leucine-rich repeat motifs. LRRC4B, in particular, is thought to play a critical role in neuronal development and the maintenance of neural networks. It is posited that LRRC4B contributes to the formation and stabilization of synapses, as well as the modulation of synaptic plasticity, which are essential for effective neural communication and long-term brain health.
The activation of LRRC4B is a complex process that likely involves several regulatory mechanisms at both the transcriptional and post-transcriptional levels. At the genetic level, the expression of LRRC4B can be upregulated in response to specific developmental cues or in reaction to environmental stimuli that necessitate changes in synaptic connectivity or neural plasticity. This regulation may be mediated by transcription factors that specifically target the promoter regions of the LRRC4B gene, enhancing its transcription in a timely and spatially specific manner. Additionally, enhancer elements and epigenetic modifications such as DNA methylation and histone acetylation can also play roles in modulating the accessibility of the LRRC4B gene to the transcriptional machinery, thereby influencing its expression levels.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $102.00 $204.00 | 13 | |
Histone acetyltransferase (HAT) activator. By promoting histone acetylation, Anacardic acid can lead to a transcriptionally active state. If LRRC4B is modulated by histone acetylation, this chemical can influence its transcription. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
P300 HAT inhibitor. By targeting P300, a major HAT, C646 can influence genes regulated by histone acetylation, potentially impacting the expression of LRRC4B if its regulation is linked to P300-mediated acetylation. | ||||||
Epz004777 | 1338466-77-5 | sc-507560 | 100 mg | $575.00 | ||
DOT1L inhibitor that targets methylation of histone H3. This action can modulate genes whose expression is linked to H3 methylation status, potentially affecting LRRC4B if it's associated with such epigenetic regulation. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
GSK-3 inhibitor. As GSK-3 is known to be involved in multiple pathways including Wnt, inhibition by BIO can affect downstream targets, possibly influencing LRRC4B if it is associated with pathways modulated by GSK-3. | ||||||
PRT4165 | 31083-55-3 | sc-507487 | 10 mg | $134.00 | ||
Inhibitor of the interaction between EZH2 and its partner proteins. By disrupting EZH2's actions, it can influence genes modulated by this methyltransferase, potentially affecting LRRC4B if its regulation involves EZH2-mediated methylation. | ||||||
EPZ6438 | 1403254-99-8 | sc-507456 | 1 mg | $66.00 | ||
EZH2 inhibitor, affecting methylation of histone H3. If LRRC4B expression or function is linked to H3 methylation status, EPZ-6438's activity can modulate its expression. | ||||||
A 83-01 | 909910-43-6 | sc-203791 sc-203791A | 10 mg 50 mg | $202.00 $811.00 | 16 | |
TGF-β type I receptor ALK5 inhibitor. By targeting ALK5, A-83-01 can influence genes downstream of the TGF-β pathway, potentially including LRRC4B if it is linked to this pathway. | ||||||